Iris.ai Closer to Creating the World's First AI Science Assistant
Iris.ai, the artificial intelligence tool which helps researchers find relevant scientific papers and journals, today announced the launch of version 4.0. The launch adds the Focus tool, an intelligent mechanism to refine and collate a reading list of research literature cutting out a huge amount of manual effort.
Read more ...
Blackpool Teaching Hospitals Triggers Digital Transformation with MAXIMS go-live
Blackpool Teaching Hospitals NHS Foundation Trust has laid the foundations for an ambitious digitisation programme, by deploying IMS MAXIMS technology in its emergency department. The go-live is already helping staff to better manage patients over the busy winter period.
Read more ...
Nominations Open for 2nd HIMSS-Elsevier Digital Healthcare Award in Europe
Elsevier, the information analytics company specialising in science and health, and HIMSS, the Healthcare Information and Management System Society, jointly announced that nominations are open for the second HIMSS-Elsevier Digital Healthcare Award in Europe.
Read more ...
Novartis Expands Alliance with Science 37 to Advance Virtual Clinical Trials Program
Novartis has announced an additional strategic alliance with Science 37, a leader in decentralized clinical trial technology and design, to initiate up to 10 new clinical trials over the next three years. The studies will blend virtual and traditional models, with increasing degrees of decentralization towards a mostly "site-less" model.
Read more ...
Novartis and Pear Therapeutics to Develop Digital Therapeutics for Patients with Schizophrenia and Multiple Sclerosis
Novartis has entered into a collaboration with Pear Therapeutics to develop novel prescription digital therapeutics, software applications designed to effectively treat disease and improve clinical outcomes for patients. The collaboration brings together Novartis expertise in biomedical research and clinical development with Pear's leading experience in digital therapeutics design and implementation.
Read more ...
FDA Permits Marketing of Clinical Decision Support Software for Alerting Providers of a Potential Stroke in Patients
Today, the U.S. Food and Drug Administration permitted marketing of the Viz.AI Contact application, a type of clinical decision support software designed to analyze computed tomography (CT) results that may notify providers of a potential stroke in their patients.
Read more ...
Abbott's App for FreeStyle® Libre System Now Available in Europe for Both iPhoneTM and AndroidTM
Abbott (NYSE: ABT) announced today the FreeStyle LibreLink app is now available in Europe for use with compatible smartphones(2) (both iPhone and Android). People with diabetes living in Europe and using the FreeStyle® Libre system(3) are now able to access glucose data directly from their smartphones, eliminating the need to carry the separate FreeStyle Libre reader(4) (a handheld device used to scan the FreeStyle Libre sensor to get a glucose result).
Read more ...
Blackpool Teaching Hospitals NHS Foundation Trust has laid the foundations for an ambitious digitisation programme, by deploying IMS MAXIMS technology in its emergency department. The go-live is already helping staff to better manage patients over the busy winter period. 
Elsevier, the information analytics company specialising in science and health, and HIMSS, the Healthcare Information and Management System Society, jointly announced that nominations are open for the second HIMSS-Elsevier Digital Healthcare Award in Europe. 
Novartis has announced an additional strategic alliance with Science 37, a leader in decentralized clinical trial technology and design, to initiate up to 10 new clinical trials over the next three years. The studies will blend virtual and traditional models, with increasing degrees of decentralization towards a mostly "site-less" model. 
Today, the U.S. Food and Drug Administration permitted marketing of the Viz.AI Contact application, a type of clinical decision support software designed to analyze computed tomography (CT) results that may notify providers of a potential stroke in their patients. 
Abbott (NYSE: ABT) announced today the FreeStyle LibreLink app is now available in Europe for use with compatible smartphones(2) (both iPhone and Android). People with diabetes living in Europe and using the FreeStyle® Libre system(3) are now able to access glucose data directly from their smartphones, eliminating the need to carry the separate FreeStyle Libre reader(4) (a handheld device used to scan the FreeStyle Libre sensor to get a glucose result).